Fluence, a company specializing in psychedelic therapy training, has partnered with Enthea, a health insurance administrator, to expand reimbursement for services from Fluence-trained clinicians offering ketamine-assisted therapy.

Under this partnership, clinicians meeting Enthea's requirements will receive a 20% discount on Fluence's Psychedelic Therapy Integration and Ketamine-Assisted Psychotherapy Certificate programs. The discount will increase to 30% if annual referrals exceed 100 participants. The collaboration aims to increase the accessibility of psychedelic-assisted therapy and expand the pool of trained therapists. 

Analyst QuickTake: In recent years, Fluence has been leveraging partnerships to expand its psychedelic-assisted therapy and practitioner training services. In May 2024 , Fluence partnered with Metamorph AI to develop a GenAI tool for psychedelic therapy training. Additionally, it partnered with several psychedelic research and development companies to offer training for psychedelic therapy, including Reunion Neuroscience (April 2024), Psyence (April 2024), and Cybin (September 2023).